A blue chip denotes the cream of the crop—the most put-together, high-quality company or share. So one can only imagine that naming your company Bluechiip would entail high expectations. And high pressure. Two years ago, advanced sampling management company Bluechiip (ASX: BCT) announced that it would directly market its Bluechiip-Enabled products to end-users, concentrating especially
Read More
Advisory and tech services company Atturra (ASX: ATA) is making headway into regional Australia, with its subsidiary Atturra Holdings acquiring Newcastle-based IT company Sabervox via a Share Purchase Agreement (SPA). As per the SPA, the acquisition will demand an upfront payment of $4 million in cash and $1 million worth of ATA shares. The deal
Read More
In the Asian market, electric vehicles are set to see massive growth, with revenue projected to reach $671 billion by 2028. Going further left, in South America, the revenue is set to grow to $3.45 billion. Rest assured, as demand grows, it helps to have an early mover advantage. It’s just one of the reasons
Read More
If you’ve ever had fears about being knocked out by a drone falling out of the sky, rest assured there is a massive regulatory hurdle for drone operators to overcome. So serious are the safety ramifications that it has taken drone company Elsight (ASX: ELS) and its tech partner Airobotics 4 years to meet the
Read More
Wave energy tech developer Carnegie Clean Energy (ASX: CCE) has been selected to receive a $6.3 million contract as part of the competitive EuropeWave Pre-Commercial Procurement (PCP) programme. The Phase 3 EuropeWave contract will engage ’s wholly-owned subsidiary CETO Wave Energy Ireland (CWEI) to build and operate a CETO wave energy converter at a European
Read More
Human resources (HR) Software-as-a-Service (SaaS) provider Schrole (ASX: SCL) has had a better August than some, as its portfolio expanded beyond schools, appealing to mining companies looking to train new recruits. It’s no wonder then that Schrole Develop, its training division, has been doing well, with sales for August 2023 at $200,000, up 34% on
Read More
In 2020, water treatment company Phoslock Environmental Technologies (ASX: PET) came under the scanner for accounting irregularities and fraud in its China division. Subsequently, the Company’s financials suffered and it also lost some staff in China. Three years later, PET’s China management team has been restructured to reduce costs and focus resources on revenue-generating activity.
Read More
In 2023, the emerging cancer diagnostics market is estimated to be valued at over $23 billion. Everything is fair game in “finding a cure to cancer”—be it potentially using blood drops or narrowing in on exosomes, which are tiny structures our cells produce to transfer messages, proteins, lipids, the good stuff. These structures might also
Read More
Gastrointestinal (GI) parasites are a pressing public health issue, affecting both humans and animals. Unfortunately, these diseases often go undiagnosed due to limited awareness among healthcare providers and the lack of available diagnostic tests. In the US, undiagnosed GI cases impact at least 12 million Americans, causing health problems either through new infections or long-lasting
Read More
In FY23, pharmaceutical company Mayne Pharma (ASX: MYX) reimagined its business to focus on dermatology and other core businesses. In line with that, the Company has entered into an asset purchase agreement to acquire the global rights to the rosacea treatment RHOFADE (oxymetazoline hydrochloride) cream from medical dermatology companies Novan and its subsidiary EPI Health.
Read More
